SPORTSSHERDOG
Sherdog.com Home
News Blog Videos Sherdog Radio Pictures MMA Statistics Sherdog Forums Sherdog Store
Fight Finder

  First Name
  Last Name
  Nick Name
News Quicklinks
» Weekend Rundown: Browning, Prangley, Clementi Victorious
» 9 Matchups Official for UFC 108
» Golden Glory Comments on Fighter Death
» Update: Machida Gets Hand Surgery, No Sparring Until Jan.
» Silva: 'My Opponent is Bisping'
» Gonzaga Out of UFC 108
» 10 Bouts Official for WEC 45
» CSAC: ‘No Conflicts’ for Big John McCarthy
» Dream vs. Sengoku on New Year’s Eve Made Official
» ‘Ninja’ Rua Signs with Shine Fights
Update: Court Upholds CSAC Suspension of Silva
 Options: | Printer Friendly
Update: Court Upholds CSAC Suspension of Silva
Friday, April 10, 2009
by Loretta Hunt (lhunt@sherdog.com)

LOS ANGELES -- The Los Angeles Superior Court upheld the California State Athletic Commission’s one-year suspension of Antonio Silva for steroid use on Friday, rejecting a “writ of mandate” ruling that would have superseded the CSAC’s findings.

Silva’s attorney, Howard Jacobs, had filed the civil action against the CSAC on Jan. 7, the first known case in which a mixed martial artist has legally contested a decision outside the state regulatory body.

The 28-year-old Brazilian was suspended after allegedly testing positive for Boldenone metabolite following his July 26 heavyweight championship contest against Justin Eilers at an EliteXC event in Stockton, Calif.

Silva’s suspension, which runs through July 27, 2009, was upheld at a CSAC appeals hearing on Oct. 22 by a five-count unanimous vote.

On Friday, Jacobs argued that the CSAC acknowledged that the positive test could have been attributed to the steroid or the over-the-counter nutritional supplement Novedex, but the state agency erroneously misplaced the burden of proof on the fighter to prove he had taken the supplement.

Jacobs also argued that Novedex is currently classified as an over-the-counter supplement, and not a drug, by the Food and Drug Administration.

Rule 303 of the California Code of Regulations states that “the use of any drugs, alcohol or stimulants, or injections in any part of the body” is prohibited by the athlete prior to a contest.

Novedex, which contains the testosterone booster ATD, is not included on the CSAC’s current list of banned substances.

However, Judge David P. Yaffe ruled that Novedex could be classified as a drug because it “enhances the structure or function of the body.”

Judge Yaffe was skeptical of Silva’s admission to Novedex use after he allegedly tested positive for the steroid (Silva did not list Novedex on his pre-fight medical paperwork), as the supplement has caused false readings for Boldenone before due to its similar metabolism into the body.

“[Novedex] makes it impossible for the test that was used to determine that your client was taking the steroids to show [he took it], because it would also show that he took this drug. That’s his excuse,” said Judge Yaffe.

Judge Yaffe said Silva’s failure to disclose his Novedex use prior to his testing could be construed as circumstantial evidence that he knew the supplement could mimic the steroid results.

Silva’s manager, Alex Davis, decried the court’s allegations.

“Antonio is still innocent. He did not use Boldenone,” wrote Davis via email following the ruling. “Novedex is not on, or wasn't on the CSAC forbidden substance list, and Antonio was not aware that it could cause a false positive.”

Jacobs, who also represented former UFC lightweight champion Sean Sherk in his steroids appeal with the CSAC in 2007, held fast to his argument that Novedex and other over-the-counter nutritional supplements are not classified as drugs.

“If the state athlete commission wants to ban substances that are in supplements, they need to change their statute. Their statute’s a joke,” Jacobs told Sherdog.com afterward. “It says that you can’t take drugs, and there’s no definition of drugs. You have an athlete from another country, who’s buying a supplement over the counter. Obviously, he’s not thinking it’s a drug because you need a prescription for a drug.”

Jacobs suggested the commission adopt a prohibited substance list, such as the one maintained by the World Anti-Doping Agency (WADA) and followed by other sports, to prevent further confusion.

The CSAC will now review Silva’s license for potential revocation following the fighter’s participation at a Jan. 4 event in Japan. Silva earned a technical knockout over Yoshihiro Nakao at World Victory Road’s “Sengoku Seventh Battle” at 1:42 of the first round.

The regulatory agency contends Silva violated the state’s Business and Professions Code 18850, which states that, “any boxer or martial arts fighter who participates in a contest or match while under suspension by the commission, or any other recognized commission, shall have his or her license revoked.”

The CSAC could freeze Silva’s California license in one-year increments until the commission votes again to reinstatement him. The commission could also vote to not revoke the license, alter Silva’s suspension, and impose a fine.

Jacobs said he would have to review the ruling with Silva and his manager Davis, who were not in attendance, before deciding their next course of action.

Editor’s Note: This article was updated at 8:45 p.m. EST to include additional information.
 

RECENT ANTONIO SILVA NEWS:
New Questions for Rogers, Mousasi & More
Monday, November 09, 2009
5 Questions: Strikeforce Edition
Saturday, November 07, 2009
Silva-Werdum Added to Strikeforce
Friday, October 09, 2009
Pictures: Sengoku 'Tenth Battle'
Friday, September 25, 2009
Sengoku 10 Quoteworthy: A Black Belt in Intensity, Devoured Macadamia Nuts & Silva Wants Barnett
Thursday, September 24, 2009
Sengoku 10 Notebook
Thursday, September 24, 2009
Search News Archive:   November 2009     October 2009     September 2009    
Sherdog.com, A property of CraveOnline, a division of AtomicOnline, LLC.
© 2009 CraveOnline Media, LLC. All Rights Reserved.
Privacy Policy | Terms of Use | RSS | Mobile | Advertise
Not in any way associated with Crave Entertainment, Inc.